Search Results for:
-
Survey: Most Biotech Deals Finish Well Short Of Potential
We have profiles of each of these companies, but my pledge has been to only share that with the big pharma companiesBioWorld Insight | Monday, January 22, 2001 -
Cambridge Drug Eyes Licensing Deals Following £7.5M Financing
Treherne said pharma companies are "very avidly" looking for discovery collaborations to build their pipelinesBy Nuala Moran | BioWorld International | Wednesday, January 17, 2001 -
Atrix Licenses Leuprogel Rights To Sanofi In Up-To-$60M Alliance
I think this gives Atrix an opportunity to be well founded as a specialty pharma companyBioWorld Today | Wednesday, January 10, 2001 -
Biotech/Big Pharma Collaborations - 2001
December December - 2001 Biotech Company Pharma Company Disclosed Potential Funding (M) Details Actelion Ltd. (Switzerland; SWX:ATLN) Neopharm Ltd. (Israel) ND Exclusive licensing agreement in which Neopharm will be responsible for the registration, marketing and reimbursement of Tracleer in Israel Actelion Ltd. (Switzerland; SWX:ATLN) Nova Factor Inc. (subsidiary of Accredo Health Inc.) and Gentiva Health Services ND Distribution agreement for Tracleer Albany Molecular Research IncBioWorld Snapshots | Saturday, January 6, 2001 -
3-Dimensional, Centocor Enter $50M Compound Collaboration
Clearly, J&J is one of the major pharma companies in the world today and they have great experience in doing large development programs such as would be required for a direct thrombin inhibitor and a lot of experience in small-molecule drug developmentBioWorld Today | Wednesday, January 3, 2001 -
Corixa Draws Down Final $37.5M From Castle Gate Credit Facility
Corixa prior to the Coulter transaction built itself in partnerships with major pharma companiesBioWorld Today | Wednesday, January 3, 2001 -
Estonia Will Build National Gene Bank With SNPs Of 1M Citizens
Metspalu said the majority of funding is expected to come from private resources such as biotech and pharma companiesBy Ranier B. Langen | BioWorld International | Wednesday, January 3, 2001 -
LION Adds Preclinical Capability Through $35M Trega Acquisition
Trega raised the data necessary for ADME prediction, from cooperations with five big pharma companiesBy Ranier B. Langen | BioWorld International | Wednesday, January 3, 2001 -
MetaPhore Raises $13M Privately For Antioxidant Drug Research
MetaPhore's collaborations include a co-exclusive agreement with the former Monsanto Co., since bought by Pharmacia Corp., of Peapack, N.J. The pharma company gets rights of first offer for anything MetaPhore develops in exchange for an equity investment totaling about $1 millionBioWorld Today | Tuesday, January 2, 2001 -
Analyst: Even After BioChem Merger, Lead Optimizing Is A Tall Order For Shire Group
As specialty pharma companies mature, they're going to be on the hots for drugs, and the big bolus of drugs exists within biotech," Sonnier noted, and Stahel already has indicated the new entity will be shopping for bargainsBioWorld Insight | Monday, December 18, 2000 -
Artecel Lands First Financing For Work In Adipose Tissue
Also, it's possible a big pharma company might match up well with Artecel, she saidBioWorld Today | Monday, December 11, 2000 -
Abgenix Expands MAb Research Deals With CuraGen, Immunex
This expansion makes for the largest antibody discovery and development collaboration in biotechnology, Milne said, and positions both companies, he added, to become the next generation of pharma company...Over the next several years this will turn CuraGen and Abgenix into the next generation of pharma companyBioWorld Today | Wednesday, November 29, 2000 -
Noxxon Brings In EUR20M For Spiegelmer Technology
According to Klein, Noxxon is in discussions with several big pharma companies concerning additional cooperative agreementsBioWorld International | Wednesday, November 29, 2000 -
Epigenomics' $24M Round Will Fund Creation Of U.S. Presence
There's a business model of partnering, offering lead-specific deals to pharma companies to generate data for clinical trialsBioWorld Today | Wednesday, November 15, 2000 -
Genelabs Enters $55M Deal With Watson For Lupus Drug Aslera
Watson has been rapidly growing, but unlike a relationship with a really major pharma company where our product might be small in comparison to other things in the portfolio, at Watson, Aslera has the potential of being very importantBioWorld Today | Tuesday, November 14, 2000 -
BioChem Pharma Acquiring Former Spinout CliniChem
BioChem purchased 8 million of its shares from research partner GlaxoWellcome Inc., of Research Triangle Park, N.C., last year, reducing the pharma company's interest from 12.2 percent to 5.3 percentBioWorld Today | Monday, October 30, 2000 -
Lion, Tripos To Provide Bayer Combination Discovery Platform
This is the first time a company has had the foresight to say, 'We could save a lot of time and be more efficient if we brought together data from all our research activity.' This is a common problem in big pharma companies throughout the world, and we see this as the first of what we hope to be a number of contracts like thisBioWorld Today | Tuesday, October 17, 2000 -
Corixa, Purdue Collaborate To To Develop Cancer Antibodies
to develop novel therapeutic antibodies against cancer based on tumor surface antigen targets, a deal that provides the pharma company with antigens isolated by CorixaBioWorld Today | Tuesday, September 26, 2000 -
Structural GenomiX Places $45M Equity To Further Protein Models
He said Structural GenomiX is currently talking to a number of big pharma companies and some larger biotech companies concerning partnerships or alliances centered on the company's protein structuresBioWorld Today | Wednesday, September 20, 2000 -
Ingenium Raises EUR50M For Work In 'Deductive' Genomics
It is seeking partnerships with pharma companies that aim to build a comprehensive understanding of their main disease areasBioWorld International | Wednesday, September 20, 2000
Category
Current Filters
- xpharma companies
Related Keywords
Categories
- x BioWorld Today (430)
- x BioWorld International (212)
- x BioWorld Insight (109)
- x Bio Perspectives (75)
- x State of the Industry Report (17)
- x BioWorld Snapshots (14)
- x Top 25 Drug Report (8)
- x BioWorld Genomics Review (4)
- x Biotech Innovations (3)
- x RNAi Report (2)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.